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Background: Ring annuloplasty has been used to correct annular dilatation and
mitral regurgitation in dilated cardiomyopathy, but little is known about the dy-
namic precise 3-dimensional geometry of the mitral annulus in this condition.
Methods: Nine sheep had radiopaque markers sewn to the mitral annulus, creating
8 distinct segments beginning at the posterior commissure (segments 1-4, septal
mitral annulus; segments 5-8, lateral mitral annulus). Biplane videofluoroscopy and
transesophageal echocardiography were performed before and after rapid pacing
(180-230 min1 for 15  6 days) sufficient to develop tachycardia-induced cardio-
myopathy and mitral regurgitation. Mitral annular segment contraction was defined
as the percentage difference between maximum and minimum lengths. Mitral
annular area and mitral annular septal-lateral and commissure-commissure diame-
ters and 3-dimensional shape were determined from marker coordinates.
Results: With tachycardia-induced cardiomyopathy, end-diastolic mitral annular
area, septal-lateral diameter, and commissure-commissure diameter increased by
36%  14%, 25%  12%, and 9%  5%, respectively (P  .01), whereas mitral
regurgitation increased from 0.3  0.2 to 2.2  0.9 (P  .0001). All annular
segments dilated at end-diastole with tachycardia-induced cardiomyopathy, except
the segment between the midseptal annulus and the left fibrous trigone. Annular
segment contraction was significantly decreased with tachycardia-induced cardio-
myopathy in the lateral, but not in the septal, regions. Three-dimensional recon-
struction of annular shape revealed a saddle shape of the annulus at baseline; this
shape was also measured with tachycardia-induced cardiomyopathy, but there was
some flattening of the septal annulus.
Conclusions: With tachycardia-induced cardiomyopathy, the mitral annulus dilated
substantially, being more in the septal-lateral than in the commissure-commissure
dimension. Greater annular segmental dilatation and decreased contraction occurred
in the lateral annulus. The saddle shape of the annulus was retained but flattened.
The mitral annulus deforms dynamically during the cardiac cycle.1Mitral annular expansion facilitates filling in diastole, whereas an-nular reduction aids leaflet coaptation and normal closure in systole.Normal annular dynamics are altered by hemodynamic conditions,1ischemia,2 and atrial contraction pattern.3,4 Mitral annular dilatationwas suggested by Boltwood and colleagues5 to be the primary cause
of functional mitral regurgitation (MR) in patients with dilated cardiomyopathy, and
recent echocardiographic studies have reported altered 3-dimensional (3-D) annular
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dynamics in patients with dilated6 and ischemic7 cardiomy-
opathy, which could contribute to mitral insufficiency. Al-
though these studies provide important insights into mitral
annular physiology in cardiomyopathic states, precise mea-
surements of annular dynamic 3-D geometry in end-stage
dilated ventricles do not exist. Even though ring annulo-
plasty can abolish MR in patients with dilated cardiomyop-
athy,8 more information is needed. Such data might lead to
improved prosthetic ring design and development of new
annular procedures that would reliably correct MR in a
durable fashion by using more physiologic repair tech-
niques.
Using myocardial marker technology, we investigated
precise mitral annular 3-D dynamic geometry before and
after the development of tachycardia-induced cardiomyop-
athy (TIC) in an ovine model. This model of end-stage heart
failure has been shown to result in MR9 and is associated
with the hemodynamic10,11 and neurohumoral12 changes
seen in human heart failure.
Methods
Surgical Preparation
The surgical preparation for myocardial marker insertion has been
described in detail previously,3 and therefore it will be summarized
only briefly here. Nine adult sheep were premedicated with ket-
amine (25 mg/kg administered intramuscularly) for venous and
arterial line placement and monitored, and anesthesia was induced
with sodium thiopental (6.8 mg/kg administered intravenously).
The animals were intubated and mechanically ventilated (Servo
Anesthesia Ventilator, Siemens-Elema AB), and anesthesia was
maintained with inhalational isoflurane (1%-2.2%). A left thora-
cotomy was performed. Eight miniature tantalum markers (inner
diameter, 0.8 mm; outer diameter, 1.3 mm; length, 1.5-3.0 mm)
were inserted beneath the left ventricular (LV) epicardial surface
along 4 equally spaced longitudinal meridians for LV volume
determination, with one marker placed at the LV apex. The right
atrium and the descending thoracic aorta were cannulated after
heparinization (300 IU/kg). After establishment of cardiopulmo-
nary bypass and cardioplegic arrest, 8 tantalum markers were
sutured to delineate the circumference of the mitral annulus (Fig-
ure 1, markers 1-8, with markers 2 and 4 corresponding to the right
and left fibrous trigones, respectively). The animal was rewarmed,
the atriotomy was closed, the crossclamp was removed, and, after
resuscitation, the animal was weaned from bypass. A microma-
nometer pressure transducer (PA4.5-X6, Konigsberg Instruments,
Inc) was placed in the LV chamber through the apex. A unipolar
pacing lead was sewn to the LV epicardium.
Experimental Protocol
After 6  1 days (mean  1 SD), each animal was taken to the
cardiac catheterization laboratory, sedated with ketamine (1-4
mg kg1 h1 of intravenous infusion) and diazepam (5-mg
intravenous bolus as needed), intubated, and mechanically venti-
lated (veterinary anesthesia ventilator 2000, Halowell EMC). An
intravenous infusion of esmolol (20-50 g kg1 min1) was
used to minimize reflex sympathetic responses. Simultaneous bi-
plane videofluoroscopy and hemodynamic data recordings were
obtained during stable steady-state conditions. Transesophageal
Doppler echocardiography was performed by an experienced
echocardiographer to assess MR. MR was graded according to the
extent and width of the regurgitant jet and categorized as none (0),
mild (1), moderate (2), moderate to severe (3), or severe
(4).
Data Acquisition
Images were acquired with the animal in the right lateral decubitus
position by using a Phillips Optimus 2000 biplane Lateral ARC
2/Poly DIAGNOST C2 system (Phillips Medical Systems) with
the image magnification set in the 9-inch fluoroscopic mode.
Marker image positions from the 2 simultaneous radiographic
views were digitized and merged to yield 3-D coordinates for each
radiopaque marker every 16.7 ms with custom-designed soft-
ware.13 Synchronized ascending thoracic aortic pressure, LV pres-
sure, and electrocardiographic voltage signals were recorded si-
multaneously during videographic data acquisition.
Pacing Protocol
After baseline data acquisition, while still sedated, a rapid-pacing
pulse generator (Prodigy S 8164, Medtronic Medical) was inserted
into a subcutaneous pocket and connected to the previously exter-
nalized LV electrode, and the animal was recovered. Rapid pacing
was initiated 24 hours later. During the pacing period, interval
transthoracic echocardiography was performed to assess LV di-
mensions, systolic LV performance, and MR (with the pacemaker
temporarily off) to guide pacing rate adjustments. The end point
for cessation of pacing was development of clinically significant
MR, LV dilatation, and heart failure. The first 2 animals were
Figure 1. Schematic representation of the mitral annular marker
array used in the study. Markers 2 and 4 correspond to the right
and left fibrous trigones, respectively. ACOM, Anterior commis-
sure; PCOM, posterior commissure; AML, anterior mitral leaflet;
PML, posterior mitral leaflet.
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paced at 180 min1, and subsequent animals were paced at 230
min1, which resulted in faster development of heart failure and
MR. The average pacing period was 15  6 days. Then the
animals were returned to the catheterization laboratory with the
pacemaker turned off before the study. Hemodynamic, marker, and
echocardiographic data were again acquired.
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the Na-
tional Society for Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996. This
study was approved by the Stanford Medical Center Laboratory
Research Animal Review Committee and conducted according to
Stanford University policy.
Data Analysis
Three consecutive steady-state beats during normal sinus rhythm
before and after rapid pacing were averaged and defined as base-
line and TIC data for each animal. During each cardiac cycle, the
time of end systole (ES) was defined as the videofluoroscopic
frame containing the point of peak negative LV rate of pressure
decrease (-dP/dt), and the time of end diastole (ED) was defined as
the image frame containing the peak of the electrocardiographic
R-wave. Instantaneous LV volume was calculated from the epi-
cardial LV markers with the use of a space-filling multiple tetra-
hedral volume method for each frame (ie, every 16.7 ms). Stroke
volume was calculated as the difference between end-diastolic
volume (EDV) and end-systolic volume (ESV; ie, stroke vol-
ume  EDV  ESV), and ejection fraction was calculated as the
difference between EDV and ESV divided by EDV. These com-
puted marker ejection fraction values underestimate ejection frac-
tion calculated by using ventriculography because marker-mea-
sured EDV includes LV wall myocardial mass (epicardial
markers).
Mitral Annular Geometry
Mitral annular area was determined by first dividing the annulus
into pie slices on the basis of the annular centroid, which were then
summed to yield total annular area. The septal-lateral (S-L) diam-
eter of the annulus was calculated as the distance between the 2
markers in the middle of the septal (anterior) and lateral (posterior)
mitral annulus (Figure 1, markers 3 and 7, respectively), and the
commissure-commissure (C-C) diameter was determined as the
distance between markers 1 and 5 (Figure 1). Annular eccentricity
was computed as C-C diameter divided by S-L diameter. Total
annular perimeter was expressed as the sum of the 8 individual
annular segment lengths, with the fibrous annulus represented by
segments D2-3 and D3-4 and the muscular annulus denoted by the
remaining 6 segments. Flexion of the septal annulus during the
cardiac cycle was calculated as the orthogonal distance from the
midseptal annulus (Figure 1, marker 3) to the least-square plane
fitted to the lateral annulus (Figure 1, markers 5, 6, 7, 8, and 1), as
described previously.14 For 3-D reconstruction of mitral annular
3-D shape, a right-handed Cartesian coordinate system was used,
with the origin located at the midseptal annulus marker (no. 3), the
y-axis passing through the LV apex (positive toward the apex), the
positive x-axis directed toward the midlateral annulus such that
marker 7 was contained in the X-Y plane, and the positive z-axis
directed toward the posterior commissure. The midseptal annulus
was chosen as the origin because it is at the center of the fibrous
annulus, which should be minimally affected by LV dilatation.
These same mitral annular measurements were also determined in
7 animals during dobutamine infusion (10 g kg1 min1) at
baseline and with TIC to assess mitral annular dynamic 3-D
geometry under stress conditions.
Statistical Analysis
All data are reported as means  1 SD, unless otherwise stated.
Hemodynamic and marker-derived data from 3 consecutive
steady-state beats were aligned at ED (t  0), and data from the 3
beats were averaged for each of the 9 animals. The data (time
aligned at ED) were analyzed from 20 frames before to 20 frames
after ED, thereby allowing evaluation of the studied variables over
the entire cardiac cycle. Data were compared by using the Student
t test for paired observations.
Results
The average animal weight was 79  10 kg. Average
cardiopulmonary bypass time was 90  27 minutes, with a
mean aortic crossclamp time of 55  7 minutes. Correct
marker position was confirmed in all animals at postmortem
examination. Hemodynamic variables before and after de-
velopment of cardiomyopathy are shown in Table 1. Con-
sistent with development of TIC, rapid pacing markedly
increased LV end-systolic and end-diastolic size and end-
diastolic pressure.
Mitral Regurgitation
Before rapid pacing, one animal had mild MR, and 2 ani-
mals had trace MR; the others had no MR. After pacing, 4
animals had mild-to-moderate MR, 2 had moderate MR, 2
had moderate-to-severe MR, and 1 had severe MR. Overall
MR grade increased from 0.2  0.3 to 2.2  0.9 (P 
.0001).
Mitral Annular Geometry
Mitral annular area, S-L and C-C diameter, and total, mus-
cular, and fibrous annular perimeter during the cardiac cycle
TABLE 1. Hemodynamics
Baseline TIC P value
HR (min1) 102 16 115 18 .15
dP/dt (mm Hg/s) 1350 219 1162 374 .29
EDV (mL) 160 57 201 67 .001
ESV (mL) 128 45 168 55 .0001
EF (%) 20 5 16 5 .006
SV (mL) 33 14 34 15 .95
LVEDP (mm Hg) 16 6 30 6 .017
LVP (mm Hg) 98 12 96 13 .8
Data are shown as mean  1 SD. See text for explanation about the
marker-calculated low ejection fraction values.
HR, Heart rate; EF, ejection fraction; SV, stroke volume; LVEDP, LV end-
diastolic pressure; LVP, maximum systolic LV pressure.
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are shown in Figure 2. All these annular parameters were
greater throughout the cardiac cycle after the development
of TIC. Table 2 summarizes annular area, S-L and C-C
diameter, total perimeter, and eccentricity with TIC at ED
and ES. Of note is the impressive increase with TIC in
mitral annular area and, in particular, the more than double
fractional increase in annular S-L diameter compared with
C-C diameter at both time points. This disproportional in-
crease in S-L diameter decreased annular eccentricity and
resulted in a more circular shape of the mitral annulus with
cardiomyopathy. Mitral annular area change from maxi-
mum to minimum during the cardiac cycle was greater at
baseline than with TIC (12.0% 7% vs 8.5% 5.7%, P
.06).
Mitral Annular Dynamics Under Stress
During dobutamine infusion, similar hemodynamics were
observed at baseline and with TIC in terms of heart rate
(146  15 vs 165  23 beats/min1, baseline vs TIC; P 
.1), LV dP/dtmax (3263 780 vs 2518 609 mm Hg/s, P
.1), LV stroke volume (35  16 vs 37  16 mL, P  .4),
and peak LV pressure (131  11 vs 124  15 mm Hg, P 
.4). Mitral annular area during inotropic stimulation at base-
line and with TIC is shown in Figure 3. Dobutamine in-
duced greater mitral annular area reduction at baseline than
in TIC conditions at both ED (12.8%  9.6% vs 2.9% 
4.1%, P  .04) and ES (15.5%  9.4% vs 4.8%  4.3%,
P  .01), indicating blunted mitral annular response to
inotropic stimulation in cardiomyopathy. During dobut-
amine infusion, mitral annular area in TIC was 51%  19%
and 64%  20% greater than baseline numbers at ED and
ES, respectively.
Regional Mitral Annular Dynamics
Table 3 summarizes baseline and TIC end-diastolic lengths,
as well as length reduction (percentage) from diastolic max-
imum to systolic minimum of each of the 8 annular seg-
ments. With the exception of D3-4, all annular segments
lengthened at ED with TIC. Interestingly, segment D2-3,
which with segment D3-4 corresponds to the fibrous annu-
lus, underwent a small but significant increase in length,
suggesting that the fibrous annulus was also dilating with
cardiomyopathy. Reduction of segment lengths in the septal
annulus during the cardiac cycle did not change with TIC,
whereas reduction of all lateral annular segments decreased
significantly. Thus the most dynamic portion of the mitral
annulus, the lateral annulus, was affected to the greatest
extent by cardiomyopathy.
3-D Mitral Annular Shape
Figure 4 shows the mitral annular 3-D shape at both ED and
ES before and after TIC. The larger end-diastolic mitral
Figure 2. Mitral annular (MA) total perimeter, muscular perimeter, fibrous perimeter (left), mitral annular area,
annular S-L diameter, and annular C-C diameter (right) at baseline (filled squares) and after TIC (open squares). A
650-ms time window centered at ED (t  0) is illustrated for all variables. Error bars indicate 1 SEM.
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annular area with cardiomyopathy was accentuated at ES
because of decreased reduction of the lateral annular seg-
ments with TIC. The annulus had a similar 3-D geometry at
baseline and with TIC both at ED and ES, with the “saddle
horn” (marker 3) elevated above an otherwise relatively
planar annulus. The end-diastolic distance from each annu-
lar marker to an annular plane fitted to all annular markers
at baseline and with TIC is shown in Figure 5. There was
some flattening of the midseptal annulus (decrease in the
end-diastolic distance from marker 3 to the mitral annular
plane from 3.3  1.0 to 2.5  1.3 mm, P  .03) and
displacement below the annular plane of the midlateral
annulus (marker 7) after the development of TIC. End-
diastolic distance of the midseptal marker (marker 3) to the
annular plane did not change during dobutamine infusion
either at baseline (3.3  1.0 vs 3.2  0.9 mm, P  .7) or
with TIC (2.5  1.3 vs 2.9  1.2 mm, P  .12), which
implies independence of the septal annular height and ino-
tropic state. Figure 6 shows the dynamics of this annular
flexion distance, which decreased in TIC relative to baseline
at ED (5.5  1.4 vs 4.4  2.4 mm, P  .005) and at ES
(8.0  1.7 vs 6.2  2.6 mm, P  .03), further suggesting
“saddle horn” flattening in cardiomyopathy. Annular flexion
(as defined by the change in this distance from ED to ES14),
however, did not change significantly with TIC (2.2  1.1
and 1.8  0.7 mm for baseline and TIC, respectively; P 
.5). Annular flexion was not affected by inotropic stimula-
tion either at baseline (2.6  0.8 and 3.5  1.4 mm before
and after dobutamine, respectively; P  .3) or with cardio-
myopathy (1.7  0.8 and 2.0  0.8 mm before and after
dobutamine, respectively; P  .5).
Discussion
Mitral ring annuloplasty in patients with dilated cardiomy-
opathy has been shown to reduce MR and improve survival
in this challenging patient population.8,15 Details of the 3-D
perturbations in mitral annular geometry associated with
end-stage dilated ventricles and MR, however, have not
been clearly defined, and this knowledge could not only
shed light on the mechanisms of MR but also provide a
basis for the design of better reparative techniques. In the
current study, using radiopaque markers and TIC as a model
of dilated cardiomyopathy, we found significant annular
dilatation (especially in the S-L dimension) and perturbed
contraction of lateral annular segments to be associated with
TIC. The 3-D annular shape and septal annular flexion were
maintained in cardiomyopathy, but flattening of the “saddle
horn” (midseptal annulus) was observed in TIC.
The extent of annular dilatation in this study is similar to
the approximately 30% increase in mitral annular area re-
ported in patients with dilated cardiomyopathy relative to
normal control subjects,6 and the 12% annular area reduc-
tion during the cardiac cycle at baseline is similar to the
13% annular area reduction in sheep reported by others.3,16
Annular dilatation alone has been suggested to result in MR
in cardiomyopathy,5 and an isolated increase of annular
perimeter by 25% with an externally adjustable ring has
been shown to cause moderate-to-severe MR in experimen-
tal animals.17
Furthermore, similar annular perimeter increase, as seen
in the present study, has been reported to result in incom-
plete mitral leaflet coaptation in a finite element analysis of
mitral dilatation in a computational model.18 Thus TIC led
to annular area and perimeter changes consistent with the
development of MR.
Analysis of individual annular segment dynamics re-
vealed longer end-diastolic length of all segments of the
muscular annulus and one segment of the fibrous annulus.
Although length increase in the fibrous annular segment was
only modest, this is a finding that confronts surgical dogma
TABLE 2. Mitral annular geometry
Baseline TIC Change (%) P value
MA area (mm2)
ED 817 146 1100 161 36 14 .00001
ES 761 150 1099 157 46 13 .00001
MA perimeter (mm)
ED 108.9 9.8 124.2 10.1 14 5 .00001
ES 105.5 10.6 124.5 9.8 18 5 .00001
S-L diameter (mm)
ED 28.2 3.5 35.1 2.6 25 12 .00002
ES 27.2 3.2 34.9 2.6 29 10 .00001
C-C diameter (mm)
ED 38.9 3.7 42.1 3.3 9 5 .0014
ES 37.4 4.2 42.3 3.2 14 6 .00001
MA eccentricity (C-C/S-L)
ED 1.37 0.16 1.20 0.06 12 8 .004
ES 1.37 0.11 1.21 0.05 11 6 .0008
Data are shown as mean  1 SD.
MA, Mitral annulus; S-L, septal-lateral; C-C, commissure-commissure.
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because it is widely believed that the fibrous annulus does
not remodel when the annulus dilates.
In prior studies the lateral annulus has been shown to be
more dynamic than the septal annulus19 and more suscep-
tible to dilatation during acute ischemia.2,19,20 Hence it is not
surprising that in the current study the most dynamic annu-
lar segments comprising the lateral annulus were most af-
fected by cardiomyopathy in terms of end-diastolic length
increase and reduction of contraction during the cardiac
cycle. Thus the lateral annulus not only underwent substan-
tial dilatation but also a decrease in its sphincteric action,
which reduces mitral annular area during the cardiac cycle.
Similar decrease in annular area reduction has been reported
in acute ischemia,2 varying hemodynamic conditions,1 and
Figure 3. Mitral annular area at baseline (squares) and with TIC (triangles) before (filled symbols) and after (open
symbols) dobutamine (DB) infusion. A 650-ms time window centered at ED (t  0) is shown for all variables.
TABLE 3. Regional mitral annular dynamics
Segment no.
End-diastolic length (mm) Length change (%)
Baseline TIC Baseline TIC
Septal annulus D1-2 13.3 3.6 15.0 4.3‡ 9.6 3.2 7.3 2.1
D2-3 11.4 2.2 12.2 2.2† 9.7 2.6 8.8 3.4
D3-4 15.6 3.1 15.9 3.5 6.5 3.1 6.8 3.1
D4-5 13.2 1.6 14.7 2.1† 10.7 3.0 9.3 4.3
Lateral annulus D5-6 11.0 2.7 13.0 3.1‡ 13.3 2.6 8.4 3.5*
D6-7 13.2 3.2 15.5 3.5‡ 13.0 4.1 9.2 4.1†
D7-8 16.4 3.2 19.6 3.5‡ 14.0 6.9 8.0 3.0*
D8-1 14.8 5.4 18.5 5.9‡ 13.8 5.7 7.4 1.4†
Segments are labeled as distances between corresponding markers (ie, D1-2  distance from marker 1 to 2 [see Figure 1]). Length change is defined as
the reduction in the percentage between diastolic maximum and systolic minimum length. *P  .05, †P  .01, ‡P  .001 versus baseline by t test for paired
comparisons.
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ventricular pacing.3 Interestingly, during dobutamine infu-
sion, annular area at baseline was considerably reduced, as
described previously,21 but only slightly in TIC. Mitral
annular response to inotropic stimulation appeared blunted
in TIC, which would further compromise the annular
sphincteric mechanism. These findings might have implica-
tions for valvular competence in patients with cardiomyop-
athy during stress conditions.
The saddle shape of the mitral annulus22 was observed at
baseline and with TIC, which correlates with the findings in
recent echocardiographic studies in patients with dilated6
and ischemic23 cardiomyopathy. At baseline, the end-dia-
stolic distance from the midseptal annulus (“saddle horn”)
to the least-squares plane of the mitral annulus was 3.3 
1.0 mm, a distance almost identical to the 3.9  1.5 mm
reported in human subjects by using magnetic resonance
imaging.24 Flattening of the midseptal annulus occurred in
TIC and is in accordance with clinical findings.6,23 The
amount of annular flexion before pacing was somewhat
smaller than in the human annulus14 and did not change
with TIC. Furthermore, neither annular flexion nor displace-
ment of the annular “saddle horn” from the annular plane
appeared to be dependent on inotropic state.
Surgical Implications
Mitral ring annuloplasty with different methods has been
used to correct mitral insufficiency in patients with cardio-
myopathy,8,25 yet the optimal form of annular repair re-
Figure 4. Left, Three-dimensional reconstruction of the mitral annulus at ED (top) and ES (bottom) at baseline (filled
squares) and after TIC (open circles). Right, Rotated view of each reconstruction as viewed from the lateral-septal
annulus to illustrate the saddle shape of the annulus. #3, Saddle horn marker; ACOM, anterior commissure; PCOM,
posterior commissure.
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mains elusive because little is known about the annular
dynamic 3-D geometry in cardiomyopathic conditions and
how it differs from normal. The current study suggests that
S-L annular dilatation is chiefly responsible for the substan-
tial mitral annular area increase associated with cardiomy-
opathy and MR. This implies that clinical approaches to
treat MR in dilated cardiomyopathy should first and fore-
most reduce this dimension to enhance more leaflet coap-
tation. Because the fibrous annulus also dilated in TIC, our
data support making the entire annulus smaller to prevent
further dilatation of the fibrous annulus, which could in turn
affect durability of the repair by contributing to subsequent
annular S-L dilatation. The mitral annulus became more
circular in TIC, and re-establishing the traditional 3:4 sys-
tolic ratio of S-L to C-C mitral annular diameters, as advo-
cated by Carpentier and coworkers,26 might be important.
Indeed, some annuloplasty rings are designed in this con-
figuration. Furthermore, because the annulus flattens in car-
diomyopathy, a repair that retains the natural saddle shape
of the annulus could be desirable. It is speculative whether
repair on the basis of these theoretic guidelines would lead
to improved or more durable clinical results; further studies
are needed to characterize more precisely mitral annular
dynamic 3-D geometry in normal human subjects and in
patients with dilated or ischemic cardiomyopathy.
Limitations
Several limitations of this study must be emphasized before
extrapolating these observations to the clinical context.
Myocardial marker studies require suturing miniature tan-
talum markers to the cardiac structures of interest, and the
presence and collective mass of the markers might alter
normal annular motion. The markers used in this study,
however, were very light (4-8 mg) and would not be ex-
pected to affect the normal dynamics of the mitral annulus.
Interspecies differences in annular anatomy27 might limit
the clinical relevance of these data, but human and ovine
annular dynamics are similar during the cardiac cycle.3,28
Finally, although a rapid pacing cardiomyopathy prepara-
tion offers a good model of human congestive heart fail-
ure,10,11 it does not precisely mimic all the clinical changes
seen in dilated cardiomyopathy. Finally, immediately after
cessation of rapid pacing, biochemical, neurohumoral, mor-
phologic, and functional parameters quickly begin to return
to normal.29 This probably did not affect the data obtained
in this experiment because the TIC measurements were
obtained within minutes after cessation of pacing.
We appreciate the superb technical assistance provided by
Mary K. Zasio, BA, Carol W. Mead, BA, Erin M. Schultz, BS, and
Maggie Brophy, AS.
Figure 5. End-diastolic distance of each annular marker from the least-squares plane fitted to all annular markers
before (filled squares) and after (open squares) development of TIC. Marker numbers, as shown in Figure 1. Error
bars indicate 1 SEM. *P < .05 and **P < .01 by means of t test for paired comparisons.
Surgery for Acquired Cardiovascular Disease Timek et al




1. Tsakiris AG, Von Bernuth G, Rastelli GC, Bourgeois MJ, Titus JL,
Wood EH. Size and motion of the mitral valve annulus in anesthetized
intact dogs. J Appl Physiol. 1971;30:611-8.
2. Glasson JR, Komeda M, Daughters GT, Bolger AF, Karlsson MO,
Foppiano LE, et al. Early systolic mitral leaflet “loitering” during
acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 1998;
116:193-205.
3. Glasson JR, Komeda M, Daughters GT, Foppiano LE, Bolger AF, Tye
TL, et al. Most ovine mitral annular 3-D size reduction occurs before
ventricular systole and is abolished with ventricular pacing. Circula-
tion. 1997;96:II115-23.
4. Timek TA, Lai DT, Dagum P, Green GR, Glasson JR, Daughters GT,
et al. Mitral annular dynamics during rapid atrial pacing. Surgery.
2000;128:361-7.
5. Boltwood CM, Tei C, Wong M, Shah PM. Quantitative echocardiog-
raphy of the mitral complex in dilated cardiomyopathy: the mecha-
nism of functional mitral regurgitation. Circulation. 1983;68:498-508.
6. Flachskampf FA, Chandra S, Gaddipatti A, Levine RA, Weyman AE,
Ameling W, et al. Analysis of shape and motion of the mitral annulus
in subjects with and without cardiomyopathy by echocardiographic
3-dimensional reconstruction. J Am Soc Echocardiogr. 2000;13:277-
87.
7. Kaplan SR, Bashein G, Sheehan FH, Legget ME, Munt B, Li XN, et
al. Three-dimensional echocardiographic assessment of annular shape
changes in the normal and regurgitant mitral valve. Am Heart J.
2000;139:378-87.
8. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term out-
come of mitral reconstruction in cardiomyopathy. J Thorac Cardio-
vasc Surg. 1998;115:381-8.
9. Power JM, Raman J, Dornom A, Farish SJ, Burrell LM, Tonkin AM,
et al. Passive ventricular constraint amends the course of heart failure:
a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res.
1999;44:549-55.
10. Coleman HM, Pool PE, Whipple GH, Covell JW, Ross J, Braunwald
E. Congestive heart failure following chronic tachycardia. Am Heart J.
1971;81:790-8.
11. Wilson JR, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek
N. Experimental congestive heart failure produced by rapid ventricular
pacing in the dog: cardiac effect. Circulation. 1987;75:857-67.
12. Riegger AJG. The renin-angiotensin-aldosterone system, antidiuretic
hormone and sympathetic nerve activity in an experimental model of
congestive heart failure in the dog. Clin Sci (Colch). 1982;62:465-9.
13. Daughters GT, Miller DC, Schwartzkopf A, Mead CW, Ingels NB. A
comparison of two analytical systems for three-dimensional recon-
struction from biplane videoradiograms. IEEE Comput Cardiol. 1989;
15:79-82.
14. Komoda T, Hetzer R, Oellinger J, Siniawski H, Hofmeister J, Hubler
M, et al. The inflexible mitral annulus after valve prosthesis. Inherent
risk of dynamic left ventricular outflow tract obstruction. ASAIO J.
1996;42:M372-5.
15. Chen FY, Adams DH, Aranki SF, Collins JJ Jr, Couper GS, Rizzo RJ,
et al. Mitral valve repair in cardiomyopathy. Circulation. 1998;98:
II124-7.
16. Gorman JH, Jackson BM, Gorman RC, Kelley ST, Gikakis N, Ed-
munds LH Jr. Papillary muscle discoordination rather than increased
annular area facilitates mitral regurgitation after acute posterior myo-
cardial infarction. Circulation. 1997;96:II124-7.
17. Ahmadi A, Spillner G, Johannesson T. Hemodynamic changes fol-
lowing experimental production and correction of acute mitral regur-
Figure 6. Septal annulus flexion expressed as the distance of the saddle horn marker to the least-squares plane
of the lateral annulus before (filled squares) and after (open squares) TIC. A 650-ms time window centered at ED
(dashed line) is shown. Error bars indicate 1 SEM.
Timek et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 2 323
A
CD
gitation with an adjustable ring prosthesis. Thorac Cardiovasc Surg.
1988;36:313-9.
18. Kunzelman KS, Cochran RP. Annular dilatation increases stress in the
mitral valve and delays coaptation: a finite element computer model.
Cardiovasc Surg. 1997;5:427-34.
19. Glasson JR, Komeda MK, Daughters GT, Niczyporuk MA, Bolger
AF, Ingels NB, et al. Three-dimensional regional dynamics of the
normal mitral annulus during left ventricular ejection. J Thorac Car-
diovasc Surg. 1996;111:574-85.
20. Gorman JH, Gorman RC, Jackson BM, Hiramatsu Y, Gikakis N,
Kelley ST, et al. Distortions of the mitral valve in acute ischemic
mitral regurgitation. Ann Thorac Surg. 1997;64:1026-31.
21. Gorman JH, Jackson BM, Kelley ST, Melekan R, Edmunds LH Jr.
Effect of inotropic state on the size of the mitral valve annulus. Surg
Forum. 1997;48:275-8.
22. Levine RA, Handschumacher MD, Sanfilippo AJ, Hagege AA, Har-
rigan P, Marshall JE, et al. Three-dimensional echocardiographic
reconstruction of the mitral valve, with implications for the diagnosis
of mitral valve prolapse. Circulation. 1989;80:589-98.
23. Kaplan SL, Sullivan SF, Malm JR, Bowman F Jr, Papper EM. Effect
of cardiac bypass on pulmonary diffusing capacity. J Thorac Cardio-
vasc Surg. 1969;57:738-46.
24. Komoda T, Hetzer R, Uyama C, Siniawski H, Maeta H, Rosendahl
UP, et al. Mitral annular function assessed by 3D imaging for mitral
valve surgery. J Heart Valve Dis. 1994;3:483-90.
25. Bishay ES, McCarthy PM, Cosgrove DM, Hoercher KJ, Smedira NG,
Mukherjee D, et al. Mitral valve surgery in patients with severe left
ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213-21.
26. Carpentier AF, Lessana A, Relland JY, Belli E, Mihaileanu S, Berrebi
AJ, et al. The “physio-ring”: an advanced concept in mitral valve
annuloplasty. Ann Thorac Surg. 1995;60:1177-86.
27. Walmsley R. Anatomy of human mitral valve in adult cadaver and
comparative anatomy of the valve. Br Heart J. 1978;40:351-66.
28. Ormiston JA, Shah PM, Tei C, Wong M. Size and motion of the mitral
valve annulus in man. I. A two-dimensional echocardiographic
method and findings in normal subjects. Circulation. 1981;64:113-20.
29. Shinbane JS, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman
MM. Tachycardia-induced cardiomyopathy: a review of animal mod-
els and clinical studies. J Am Coll Cardiol. 1997;29:709-15.
Surgery for Acquired Cardiovascular Disease Timek et al
324 The Journal of Thoracic and Cardiovascular Surgery ● February 2003
A
CD
